Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Amitriptyline for Bladder Pain Syndrome

Evidence-Based Rationale

  • The American Urological Association recommends amitriptyline for IC/BPS with Grade B evidence strength, showing superiority over placebo for symptom improvement 1, 2, 3
  • Nortriptyline has no published evidence for bladder pain syndrome treatment and is not mentioned in any IC/BPS guidelines or research studies 1, 2, 3

Practical Dosing Algorithm for Amitriptyline in IC/BPS

  • The American Urological Association suggests beginning amitriptyline at 10 mg nightly at bedtime to minimize side effects 1, 2, 3
  • Increase amitriptyline by 10-25 mg every 3-7 days as tolerated, with a target dose of 50-75 mg daily 1, 2, 3

Critical Safety Considerations

  • The American Heart Association recommends obtaining screening ECG in patients >40 years before initiating amitriptyline therapy 4
  • Limit amitriptyline doses to <100 mg/day in patients with any cardiac risk factors 7

Common Adverse Effects

  • Sedation, dry mouth, orthostatic hypotension, constipation, urinary retention, and nausea are frequent but generally not life-threatening side effects of amitriptyline 1, 2, 3

Multimodal Treatment Approach

  • The American Urological Association recommends combining pharmacologic agents with behavioral modifications and other therapies for IC/BPS treatment 1, 2, 3

Alternative Agents

  • Pentosan polysulfate has Grade B evidence for IC/BPS treatment but requires counseling about macular damage risk 1, 2, 3